OLYMPUSby New Odyssey
Menu
SEC registrant · CIK 0001113481

MEDICINES CO /DE

MEDICINES CO /DE (CIK 0001113481, EIN 04-3324394) reported revenue of $6.14 million ($6,138,000) for FY2018 (2018-01-01 to 2018-12-31) and net income of -$123.16 million (-$123,156,000) for FY2018 (2018-01-01 to 2018-12-31), as filed in its 10-K filed 2019-02-27 (accession 0001113481-19-000005).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends December 31).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0001113481
EIN04-3324394
SIC industry code2834 Pharmaceutical Preparations
State or country of incorporationDE
Fiscal year endDecember 31
Filer categoryLarge accelerated filer
Entity typeoperating
Olympus entity IDorg_7h2p0bwkb3aeb8xr14pe9pzymb
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Revenue$6,138,000FY20182018-01-01 to 2018-12-3110-K2019-02-270001113481-19-000005RevenueFromContractWithCustomerExcludingAssessedTax
Net income-$123,156,000FY20182018-01-01 to 2018-12-3110-K2019-02-270001113481-19-000005NetIncomeLoss
Total assets$841,686,000FY2018as of 2018-12-3110-K2019-02-270001113481-19-000005Assets
Total liabilities$863,950,000FY2018as of 2018-12-3110-K2019-02-270001113481-19-000005Liabilities
Stockholders' equity-$22,264,000FY2018as of 2018-12-3110-K2019-02-270001113481-19-000005StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
Operating cash flow-$261,795,000FY20182018-01-01 to 2018-12-3110-K2019-02-270001113481-19-000005NetCashProvidedByUsedInOperatingActivities
Diluted earnings per share-$1.68 per shareFY20182018-01-01 to 2018-12-3110-K2019-02-270001113481-19-000005EarningsPerShareDiluted
Shares outstanding73,862,176 sharesFY2018as of 2019-02-2510-K2019-02-270001113481-19-000005EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2009-2018, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
RevenueFY20182018-01-01 to 2018-12-31$6,138,00010-K2019-02-270001113481-19-000005
RevenueFY20172017-01-01 to 2017-12-31$44,789,00010-K2019-02-270001113481-19-000005
RevenueFY20162016-01-01 to 2016-12-31$143,161,00010-K2019-02-270001113481-19-000005
RevenueFY20152015-01-01 to 2015-12-31$294,547,00010-K2018-03-010001113481-18-000017
RevenueFY20142014-01-01 to 2014-12-31$1,300,00010-K2015-03-020001113481-15-000011
RevenueFY20132013-01-01 to 2013-12-31$5,100,00010-K2015-03-020001113481-15-000011
RevenueFY20122012-01-01 to 2012-12-31$5,500,00010-K2015-03-020001113481-15-000011
RevenueFY20112011-01-01 to 2011-12-31$6,000,00010-K2014-03-030001113481-14-000016
RevenueFY20102010-01-01 to 2010-12-31$437,645,00010-K2013-03-010001113481-13-000009
Net incomeFY20182018-01-01 to 2018-12-31-$123,156,00010-K2019-02-270001113481-19-000005
Net incomeFY20172017-01-01 to 2017-12-31-$708,373,00010-K2019-02-270001113481-19-000005
Net incomeFY20162016-01-01 to 2016-12-31-$119,118,00010-K2019-02-270001113481-19-000005
Net incomeFY20152015-01-01 to 2015-12-31-$352,756,00010-K2018-03-010001113481-18-000017
Net incomeFY20142014-01-01 to 2014-12-31-$32,210,00010-K2017-03-010001113481-17-000010
Net incomeFY20132013-01-01 to 2013-12-31$15,512,00010-K2016-02-290001113481-16-000058
Net incomeFY20122012-01-01 to 2012-12-31$51,170,00010-K2015-03-020001113481-15-000011
Net incomeFY20112011-01-01 to 2011-12-31$127,877,00010-K2014-03-030001113481-14-000016
Net incomeFY20102010-01-01 to 2010-12-31$104,635,00010-K2013-03-010001113481-13-000009
  • Revenue for FY2015 was restated: first reported as $309,007,000 (accession 0001113481-16-000058, filed 2016-02-29).
  • Net income for FY2014 was restated: first reported as -$32,348,000 (accession 0001113481-15-000011, filed 2015-03-02).
  • Net income for FY2013 was restated: first reported as $15,260,000 (accession 0001113481-14-000016, filed 2014-03-03).

Recent 10-K and 10-Q filings

The 12 most recent 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-Q2019-10-302019-09-300001113481-19-000029mdco930201910-qxq32019.htm
10-Q2019-07-242019-06-300001113481-19-000024mdco630201910-qxq22019.htm
10-Q2019-04-262019-03-310001113481-19-000015mdco331201910-qxq12019.htm
10-K2019-02-272018-12-310001113481-19-000005mdco-12312018x10kxq42018.htm
10-Q2018-11-082018-09-300001113481-18-000049mdco930201810-qxq32018.htm
10-Q2018-08-022018-06-300001113481-18-000041mdco630201810-qxq22018.htm
10-Q2018-05-092018-03-310001113481-18-000032mdco331201810-qxq12018.htm
10-K2018-03-012017-12-310001113481-18-000017mdco-12312017x10kxq42017.htm
10-Q2017-11-092017-09-300001113481-17-000040mdco0930201710-qxq32017.htm
10-Q2017-08-092017-06-300001113481-17-000030mdco630201710-qxq22017.htm
10-Q2017-05-052017-03-310001113481-17-000017mdco0331201710-qxq12017.htm
10-K2017-03-012016-12-310001113481-17-000010mdco-12312016x10kxye2016.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0001113481published by the sourcedata.sec.gov/submissions/CIK0001113481.json2026-10-21
Employer Identification Number (EIN) · US-EIN04-3324394published by the sourcedata.sec.gov/submissions/CIK0001113481.json2026-10-21

Former names

NameFromTo
MEDICINES CO/ MA2000-08-312003-02-14

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0001113481.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0001113481.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001113481" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001113481/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001113481/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"1113481"}

On SEC EDGAR

About this data